Cytochrome P-450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans
about
Cellular and molecular biology of aging endothelial cellsAging and vascular endothelial function in humansRedundant vasodilator pathways underlying radial artery flow-mediated dilation are preserved in healthy aging.Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults.Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humansEpoxyeicosatrienoic acids and endothelium-dependent responses.The impact of age on vascular smooth muscle function in humans.Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure.Contribution of nitric oxide in the contraction-induced rapid vasodilation in young and older adultsVascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthaseCardiovascular consequences when nitric oxide and lipid signaling converge.Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Habitual aerobic exercise does not protect against micro- or macrovascular endothelial dysfunction in healthy estrogen-deficient postmenopausal women.Endothelial cell senescence with aging in healthy humans: prevention by habitual exercise and relation to vascular endothelial function.Polyphenols decreased liver NADPH oxidase activity, increased muscle mitochondrial biogenesis and decreased gastrocnemius age-dependent autophagy in aged rats.
P2860
Q28081013-8D63E527-D9C2-454B-8EDD-1FB91C90670FQ28390251-EE47F3AF-9EE6-4B1F-8067-7A8201EE049BQ33747531-5A6BBFDF-3EFD-43AA-9904-C80BFD37F876Q33894523-29A5F2D1-8911-49BA-9C8C-06F4873BBA58Q34545820-1A0710CE-08DC-47D6-96D7-6E64E493024FQ36027656-1F4509F2-DE7C-40DD-92B9-6BAE03058334Q36348267-EA4242FB-E708-46FA-958B-E3B8D44DCED9Q36545354-2F42B860-1EA4-445A-B3CE-C30D5B8BE9B5Q37093962-2930AFEF-259F-4ED2-BED8-76E05620D365Q37264432-C5E8A5BA-3ED5-4C5D-BEAD-280A49D38698Q37412845-91DC9D4C-C582-4886-83AA-05C85D571DA6Q37643511-5185FDB3-2237-418B-AE21-0E802E57D163Q37995534-64313D53-2EF7-4F3E-BF56-3748F9482024Q47158979-97456465-F7F3-46BD-B405-F5BCA96567DAQ47710227-62B406B8-1858-4545-9C87-ACC82A1876DFQ50510778-6164D908-5269-4951-A67C-F868DFF36B67
P2860
Cytochrome P-450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cytochrome P-450 2C9 signaling ...... othelial dysfunction in humans
@en
type
label
Cytochrome P-450 2C9 signaling ...... othelial dysfunction in humans
@en
prefLabel
Cytochrome P-450 2C9 signaling ...... othelial dysfunction in humans
@en
P2093
P2860
P1476
Cytochrome P-450 2C9 signaling ...... othelial dysfunction in humans
@en
P2093
Anthony J Donato
Douglas R Seals
Gary L Pierce
Iratxe Eskurza
Lindsey B Gano
P2860
P304
P356
10.1152/JAPPLPHYSIOL.90629.2008
P407
P577
2008-07-31T00:00:00Z